Advertisement

Reactions Weekly

, Volume 1780, Issue 1, pp 264–264 | Cite as

Nivolumab

Bullous pemphigoid: case report
Case report
  • 51 Downloads

Reference

  1. Gran F, et al. Bullous pemphigoid developing upon immune checkpoint inhibition with nivolumab. European Journal of Dermatology 29: 448-449, No. 4, Jul-Aug 2019. Available from: URL: http://doi.org/10.1684/ejd.2019.3614 - GermanyPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG 2019

Personalised recommendations